$1.420
+0.041 (+2.90%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Zhengye Biotechnology Holding Ltd (ZYBT) Moving Averages Convergence Divergence (MACD) indicator is -0.01, suggesting ZYBT is Neutral.
Zhengye Biotechnology Holding Ltd (ZYBT) 20-Day simple moving average is 1.44, while Zhengye Biotechnology Holding Ltd (ZYBT) share price is $—, making it Sell.
Zhengye Biotechnology Holding Ltd (ZYBT) 60-Day simple moving average is 1.49, while Zhengye Biotechnology Holding Ltd (ZYBT) share price is $—, making it Sell.
Technical Analysis for ZYBT
AI Technical ZYBTAs of 2026-11-02, the technical board for Zhengye Biotechnology Holding Ltd (ZYBT) reads neutral: 4 indicators are flashing buy, 4 are indicating sell, and 4 are neutral. Price at $1.42 sits below the 20-day and 60-day moving averages and above the 5-day, 10-day and 200-day.
Momentum readings: RSI stands at 55.527, MACD stands at -0.00605 (Sell), Stochastic %K stands at 63.563, Stochastic %D stands at 49.224 and CCI stands at -3.72.
ZYBT trades below the 60-day SMA (1.49) and above the 200-day SMA (1.16). Immediate resistance sits at Classic R1 1.54, then R2 1.68. Support sits at Classic S1 1.21, then S2 1.02.
Zhengye Biotechnology Holding Ltd (ZYBT) Support & Resistance Level
Zhengye Biotechnology Holding Ltd (ZYBT) Technical Indicators
2026-11-03
| Name | Value |
|---|---|
| RSI_14 | 55.527 |
| STOCHk_14_3_3 | 63.563 |
| STOCHd_14_3_3 | 49.224 |
| CCI_20 | -3.720 |
| AO_5_34 | -0.029 |
| MACD_12_26_9 | -0.006 |
Zhengye Biotechnology Holding Ltd (ZYBT) Relative Strength Index (RSI_14) is 55.527, creating a Neutral signal.
Zhengye Biotechnology Holding Ltd (ZYBT) Stochastic %K is 63.563, creating a Neutral signal.
Zhengye Biotechnology Holding Ltd (ZYBT) Stochastic %D is 49.224, creating a Neutral signal.
Zhengye Biotechnology Holding Ltd (ZYBT) CCI_20 is -3.720, creating a Neutral signal.
Zhengye Biotechnology Holding Ltd (ZYBT) Awesome Oscillator (AO) is -0.029, creating a Sell signal.
Zhengye Biotechnology Holding Ltd (ZYBT) Moving Average Convergence Divergence (MACD) is -0.006, creating a Sell signal.
Zhengye Biotechnology Holding Ltd (ZYBT) Moving Average
2026-11-03
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 1.384 | Buy |
| MA_10 | 1.393 | Buy |
| MA_20 | 1.444 | Sell |
| MA_60 | 1.485 | Sell |
| MA_200 | 1.163 | Buy |
| MA_250 | 1.277 | Buy |
Zhengye Biotechnology Holding Ltd (ZYBT) 5-Day simple moving average is 1.384, while Zhengye Biotechnology Holding Ltd (ZYBT) share price is $, making it a Buy.
Zhengye Biotechnology Holding Ltd (ZYBT) 10-Day simple moving average is 1.393, while Zhengye Biotechnology Holding Ltd (ZYBT) share price is $, making it a Buy.
Zhengye Biotechnology Holding Ltd (ZYBT) 20-Day simple moving average is 1.444, while Zhengye Biotechnology Holding Ltd (ZYBT) share price is $, making it a Sell.
Zhengye Biotechnology Holding Ltd (ZYBT) 60-Day simple moving average is 1.485, while Zhengye Biotechnology Holding Ltd (ZYBT) share price is $, making it a Sell.
Zhengye Biotechnology Holding Ltd (ZYBT) 200-Day simple moving average is 1.163, while Zhengye Biotechnology Holding Ltd (ZYBT) share price is $, making it a Buy.
Zhengye Biotechnology Holding Ltd (ZYBT) 250-Day simple moving average is 1.277, while Zhengye Biotechnology Holding Ltd (ZYBT) share price is $, making it a Buy.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.